Finance

Lists
OM:NASDAQ
Outset Medical Inc
US$ ४.३२
+६.९३%
(+०.२८) 1D
US$ ४.३२
०.००% (०.००)
After hours
Closed: जुलाई २७, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OM...
Open
US$ ४.१४
High
US$ ४.४३
Low
US$ ४.१२
Mkt. cap
८.०१ करोड
Avg. vol.
२.६४ लाख
Volume
७०.१४ हजार
52-wk high
US$ १८.५६
52-wk low
US$ ३.००
EPS
-US$ ४.१५
Beta
१.९५
Shares outstanding
१.८५ करोड
No. of employees
३१०
Open
US$ ४.१४
High
US$ ४.४३
Low
US$ ४.१२
Mkt. cap
८.०१ करोड
Avg. vol.
२.६४ लाख
Volume
७०.१४ हजार
52-wk high
US$ १८.५६
52-wk low
US$ ३.००
EPS
-US$ ४.१५
Beta
१.९५
Shares outstanding
१.८५ करोड
No. of employees
३१०
News stories
From sources across the web
About Outset Medical Inc
CEO-
Employees३१०
Founded२००३
Headquartersसान होसे, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to OM in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OM in the last 3 months.
Highest
Current US$ ४.३२
US$ १०.०० (+१३१.४८%)
Average
US$ ७.६७ (+७७.५५%)
Lowest
US$ ६.०० (+३८.८९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Shagun Singh Chadha
RBC Capital
Hold
Maintained
US$ ७.००
+६२%
07/13/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$ १०.००
+१३१.५%
05/08/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
US$ ६.००
+३८.९%
05/08/2026
William Katz
TD Cowen
Buy
Reiterated
US$ १२.००
+१७७.८%
04/07/2026
Marie Thibault
BTIG
Buy
Maintained
US$ १५.००
+२४७.२%
02/18/2026
Next call १० दिनमा
अगस्ट ६, बिहि, २२:३०
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -US$ ०.७२
Revenue / Est. (USD)
- / २.९० करोड
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
३.१४ करोड
२.९४ करोड
२.८९ करोड
२.७९ करोड
Cost of goods sold
१.९६ करोड
१.७८ करोड
१.६६ करोड
१.५८ करोड
Cost of revenue
१.९६ करोड
१.७८ करोड
१.६६ करोड
१.५८ करोड
Research and development expenses
५२.८९ लाख
५३.७६ लाख
५०.५५ लाख
५६.१८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.३४ करोड
२.२० करोड
२.४८ करोड
२.३४ करोड
Operating expense
२.८७ करोड
२.७४ करोड
२.९९ करोड
२.९० करोड
Total operating expenses
४.८३ करोड
४.५२ करोड
४.६५ करोड
४.४८ करोड
Operating income
-१.६९ करोड
-१.५८ करोड
-१.७६ करोड
-१.६९ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-१.८४ करोड
-१.७४ करोड
-१.९४ करोड
-१.८८ करोड
EBT excluding unusual items
-१.८४ करोड
-१.७४ करोड
-१.९४ करोड
-१.८८ करोड
Income tax expense
१.०४ लाख
४.०४ लाख
९५.०० हजार
२.१७ लाख
Effective tax rate
-०.५६%
-२.३२%
-०.४९%
-१.१६%
Other operating expenses
-
-
-
-
Net income
-१.८५ करोड
-१.७८ करोड
-१.९५ करोड
-१.९० करोड
Net profit margin
-५९.०१%
-६०.६१%
-६७.५०%
-६८.११%
Earnings per share
-०.८४
-०.६९
-०.८४
-०.८३
Interest and investment income
१९.०३ लाख
१८.५५ लाख
१६.७४ लाख
१५.२७ लाख
Interest expense
-३४.७५ लाख
-३४.७६ लाख
-३४.४१ लाख
-३३.६९ लाख
Net interest expenses
-१५.७२ लाख
-१६.२१ लाख
-१७.६७ लाख
-१८.४२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.५७ करोड
-१.४८ करोड
-१.६७ करोड
-१.६१ करोड
Gain or loss from assets sale
२.०० हजार
३.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more